What evidence-based management strategies are recommended for chronic refractory dyspnea in cancer patients?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18488690
Cited by: 0

Abstract

Chronic refractory dyspnea in cancer patients is managed through a combination of non-pharmacologic measures, such as fan therapy and exercise, along with pharmacologic interventions, with opioids playing a central role.

Fields of Study & Subjects

Pain Management and Opioid Use Palliative and Oncologic Care Cancer survivorship and care

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
30 January 2026